ABOUT 16th_ELSF
> ATTENDEES​
​> INVESTORS​
> PRESENTERS​
​> SPONSORS​
​> SUPPORTERS​

+ND Capital
3B Future Health Ventures
AATec Medical GmbH
AbbVie Ventures
AbbVie, Inc.
abcDNA GmbH
Abingworth LLP
AC BioScience SA
Acthera Therapeutics Ltd.
Actimed Therapeutics Ltd.
Adoram Therapeutics SA
Advanced Clinical
Affirma Biotech S.L.
AFK & Partners Asset Management LLC
Agile Capital Markets
AGTC Ventures LLC
Ahead Therapeutics S.L.
Alentis Therapeutics AG
Aleta Biotherapeutics
AlphaMol Science AG
Amniotics AB
Amphista Therapeutics Ltd.
AMR Action Fund GP GmbH
Amyl Therapeutics
Anchor
Andera Partners
Antion Biosciences SA
Apmonia Therapeutics
Apogenix AG
Apollo Health Ventures
ARTO AG
AstraZeneca
AstriVax NV
ATGN Consulting
Atlas Capital Advisors LLC
Atlas Capital Markets
Atriva Therapeutics GmbH
Augustine Therapeutics NV
Axon Partners Group
Azafaros B.V.
Barcode Nanotech
BaseLaunch
BAYOOMED GmbH
Bergmann zur Hausen & Cie. GmbH
Berlin Partner für Wirtschaft und Technologie GmbH
BERNINA BioInvest Ltd.
BGV (BioGeneration Ventures)
Bio Capital Impact Fund
BioMedPartners AG
BioMedVC AG
Biomunex Pharmaceuticals
BioNTech SE
Biopôle SA
BIOSTART Consulting GmbH
BioVersys AG
BiPER Therapeutics
Bird & Bird LLP
Bloomberg Intelligence
Boehler Life Science Advice
Bootstrap Europe
Bpifrance
Breslin AG & LSFA
BROTHERS & Partners Europe
Calciscon AG
Calliditas Therapeutics AB
Cantargia AB
Capricorn Partners
CBT Advisors
CD-Venture GmbH
Cellestia Biotech AG
Charles River Laboratories International, Inc.
CIS Pharma AG
Cohesion Bureau
Convergence Partners AG
Corinthian Financial Management SARL
Coulter Partners
Cukierman & Co. Life Sciences
Delin Ventures
Digital Networks Plc. S.r.l.
Dimericon Therapeutics AG
Eli Lilly & Co
Endogena Therapeutics Inc.
Epics Therapeutics
EQT Life Sciences
ETH Zurich
ExcellGene SA
Eyevensys
Forbion
Forty51 Ventures
FutuRx
GeNeuro SA
GenSearch Switzerland GmbH
Gimv
GLSV GmbH iL, MicroCures Inc, Neurevo GmbH
Grabulovski Consulting Services GmbH
GrayBella Capital LLC
H. Lundbeck A/S
H.C. Wainwright & Co., LLC
HBM Partners AG
HeartBeat.bio AG
Hephaistos Pharma
High-Tech Gründerfonds Management GmbH
Hitachi Ventures GmbH
HitchinRock Advisors Limited
Hoxton Ventures
IAG Italian Angels for Growth
IAMA Therapeutics S.r.l.
ICF Consult Switzerland
Indaco Bio Fund
Indaco Venture Partners SGR S.p.A.
Independent - LC
Independent - RM
Industrifonden
Inflexion Private Equity Partners
InnoMedica
InnoUp Farma
Instinctif Partners
Intermediate Capital Group Plc
Intravacc B.V.
Inveready
invIOs GmbH
IOME Bio
iOmx Therapeutics AG
Jefferies International Ltd.
Jeito Capital
Johnson & Johnson Innovation LLC
JPMorgan Chase & Co.
Karista
Karla Therapeutics
KBio
Kither Biotech S.r.l.
Kizoo Technology Capital GmbH
Kreos Capital
Kurma Partners
Labatec Pharma SA
LanceBio Ventures
Landmark BioVentures AG
Leman Biotech Lausanne SA
LifeLink Ventures

Lifespin GmbH
Limula SA
LMU Munich
LOGSCALE Venture Partners
LSV Capital Partners
Lynx Financial
Lys Therapeutics
Macomics Ltd.
MC Services AG
MEDiSTRAVA Consulting
Memo Therapeutics AG
Merck Healthcare KGaA
Merck KGaA, Darmstadt, Germany
Mestag Therapeutics Ltd.
MetrioPharm AG
Mobilus Fund Management oü
Momentum Biotech LLC
MSD
MV BioTherapeutics SA
Nanoligent SL
Natiggs GmbH
Neurimmune AG
Neurotech Reports
NEUWAY Pharma GmbH
New Science Fund
New York Academy of Sciences
Nextech Invest Ltd.
NGT Healthcare II
NLC – The European Healthtech Venture Builder BV
Norgine Ventures Management Limited
Novartis AG
Novartis Venture Fund
Novigenix SA
Novo Holdings A/S
Novo Nordisk A/S
Novo Ventures
NRW.BANK
NxR Biotechnologies GmbH
OCT Clinical GmbH
OMass Therapeutics
OncoOne Research & Development GmbH
Optimum Strategic Communications
Orion Biotechnology Canada, Ltd.
Orthox Ltd.
Oryzon Genomics, S.A.
Otten Life Sciences Consulting Sàrl
Oxford Science Enterprises
Palobiofarma S.L.
Parithera SA
Paul Larue Business Dev
PDC*line Pharma SA
Peregrine Ventures
Perspix Biotech GmbH
Pfizer, Inc.
PFR Ventures
PharmaVentures Ltd.
Pictet & Cie SA
Prokarium Ltd.
Proxygen GmbH
Pureos Bioventures
RBV Capital
RBW Consulting
Redx Pharma Plc.
Refoxy Pharmaceuticals GmbH
Rejuveron Telomere Therapeutics AG
Rejuveron Vascular Therapeutics
Relief Therapeutics Holding SA
Rest Therapeutics SAS
Rewind Therapeutics
Roca Therapeutics
Roy Consulting
Sachs Associates
Schroders Capital
SciRhom GmbH
Second Thought
Seekyo
Seroba Life Sciences
Somagenetix AG
Sound Bioventures Management AB
SpliceBio S.L
Staatz Business Development & Strategy
STALICLA SA
StemInov SAS
Strategic Transactions Advisory AG
Supernova Invest
SVF Vaccines AB
Swiss Biotech Association
Symeres
Syncona Investment Management Ltd.
TargImmune Therapeutics AG
Targovax ASA
Tecan Trading AG
Telum Therapeutics
Tensor Ventures
The FreeMind Group
TheraVenture GmbH
TILT Biotherapeutics Ltd
TolerogenixX GmbH
TOLREMO Therapeutics AG
Torrey Pines Investment
Torrey Pines Investment LLC
Torreya
Trawsfynydd Therapeutics, Inc.
Tridek-One SAS
TruVenturo GmbH
Turos Capital AG
TVM Capital Life Science
Twelve Bio ApS
Ultimovacs ASA
UNION therapeutics A/S
Università Svizzera Italiana
University of Zurich
University of Zurich (UZH)
V-Bio Ventures BV
Vaccentis AG
Valo Therapeutics Oy
Valor Management S.A.
valuationLAB AG
Ventac Partners A/S
Venture Valuation Inc.
VERAXA Biotech GmbH
veriNOS pharmaceuticals GmbH
Versameb AG
Verve Ventures
VI Partners AG
Viopas Venture Consulting
VirdisGroup
Vogel BioC
Wellington Partners
Wille Finance AG
X-Chem, Inc.
XGEN Venture SGR S.p.A.
Xintela AB
XNK Therapeutics AB
XOventure GmbH
Ymmunobio AG
Ysios Capital Partners S.G.E.I.C., S.A.

Last updated on: 22nd of February